Cobolimab with dostarlimab and docetaxel for treating advanced non-small-cell lung cancer after anti-PD-L1 treatment and chemotherapy [ID6398]

  • In development
  • GID-TA11500
  • Expected publication date: TBC

NIHRIO BN: 30985-Cobolimab-Dostarlimab-Docetaxel-for-Advanced-Non-Small-Cell-Lung-Cancer-V1.0-DEC2023-NON-CONF.pdf (nihr.ac.uk)